These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 10792625)
1. Effects of spironolactone on systolic blood pressure in experimental diabetic rats. Liu YJ; Nakagawa Y; Toya K; Wang Y; Saegusa H; Nakanishi T; Ohzeki T Kidney Int; 2000 May; 57(5):2064-71. PubMed ID: 10792625 [TBL] [Abstract][Full Text] [Related]
2. Gene expression of 11beta-hydroxysteroid dehydrogenase type 1 and type 2 in the kidneys of insulin-dependent diabetic rats. Liu YJ; Nakagawa Y; Ohzeki T Hypertension; 1998 Mar; 31(3):885-9. PubMed ID: 9495277 [TBL] [Abstract][Full Text] [Related]
3. Distinct ontogeny of glucocorticoid and mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase types I and II mRNAs in the fetal rat brain suggest a complex control of glucocorticoid actions. Diaz R; Brown RW; Seckl JR J Neurosci; 1998 Apr; 18(7):2570-80. PubMed ID: 9502816 [TBL] [Abstract][Full Text] [Related]
4. Uninephrectomy reduces 11β-hydroxysteroid dehydrogenase type 1 and type 2 concomitantly with an increase in blood pressure in rats. Lauterburg M; Escher G; Dick B; Ackermann D; Frey FJ J Endocrinol; 2012 Sep; 214(3):373-80. PubMed ID: 22739210 [TBL] [Abstract][Full Text] [Related]
5. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts. Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755 [TBL] [Abstract][Full Text] [Related]
6. Coexpression of mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenase 2 in human gastric mucosa. Kato K; Sasano H; Ohara S; Sekine H; Mochizuki S; Mune T; Yasuda K; Nagura H; Shimosegawa T; Toyota T; Krozowski Z J Clin Endocrinol Metab; 1999 Jul; 84(7):2568-73. PubMed ID: 10404838 [TBL] [Abstract][Full Text] [Related]
7. 11beta-hydroxysteroid dehydrogenase and corticosteroid action in lyon hypertensive rats. Lloyd-MacGilp SA; Nelson SM; Florin M; Lo M; McKinnell J; Sassard J; Kenyon CJ Hypertension; 1999 Nov; 34(5):1123-8. PubMed ID: 10567193 [TBL] [Abstract][Full Text] [Related]
8. Regulation of 11beta-hydroxysteroid dehydrogenase enzymes by dietary sodium in the rat. McKinnell J; Roscoe D; Holmes MC; Lloyd-MacGilp SA; Kenyon CJ Endocr Res; 2000 Feb; 26(1):81-95. PubMed ID: 10711725 [TBL] [Abstract][Full Text] [Related]
10. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats. Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458 [TBL] [Abstract][Full Text] [Related]
11. Effect of angiotensin II on rat renal cortical 11beta-hydroxysteroid dehydrogenase. Hermans JJR ; Fischer MA; Schiffers PM; Struijker-Boudier HA Endocrine; 2000 Dec; 13(3):393-9. PubMed ID: 11216653 [TBL] [Abstract][Full Text] [Related]
12. LLC-PK1 cells model 11 beta-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors. Leckie C; Chapman KE; Edwards CR; Seckl JR Endocrinology; 1995 Dec; 136(12):5561-9. PubMed ID: 7588309 [TBL] [Abstract][Full Text] [Related]
13. High dietary potassium chloride intake augments rat renal mineralocorticoid receptor selectivity via 11beta-hydroxysteroid dehydrogenase. Hermans JJ; Fischer MA; Schiffers PM; Struijker-Boudier HA Biochim Biophys Acta; 1999 Nov; 1472(3):537-49. PubMed ID: 10564768 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of 11beta-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis. Ackermann D; Vogt B; Escher G; Dick B; Reichen J; Frey BM; Frey FJ Hepatology; 1999 Sep; 30(3):623-9. PubMed ID: 10462366 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation. Slight SH; Chilakamarri VK; Nasr S; Dhalla AK; Ramires FJ; Sun Y; Ganjam VK; Weber KT Mol Cell Biochem; 1998 Dec; 189(1-2):47-54. PubMed ID: 9879653 [TBL] [Abstract][Full Text] [Related]
17. 11beta-hydroxysteroid dehydrogenase in cultured human vascular cells. Possible role in the development of hypertension. Hatakeyama H; Inaba S; Miyamori I Hypertension; 1999 May; 33(5):1179-84. PubMed ID: 10334808 [TBL] [Abstract][Full Text] [Related]
18. 11Beta-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human placenta. Hirasawa G; Takeyama J; Sasano H; Fukushima K; Suzuki T; Muramatu Y; Darnel AD; Kaneko C; Hiwatashi N; Toyota T; Nagura H; Krozowski ZS J Clin Endocrinol Metab; 2000 Mar; 85(3):1306-9. PubMed ID: 10720080 [TBL] [Abstract][Full Text] [Related]
19. Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues. Stokes J; Noble J; Brett L; Phillips C; Seckl JR; O'Brien C; Andrew R Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1629-38. PubMed ID: 10845579 [TBL] [Abstract][Full Text] [Related]
20. Corticosteroid receptors and 11beta-hydroxysteroid dehydrogenase isoforms in rat intestinal epithelia. Sheppard KE; Li KX; Autelitano DJ Am J Physiol; 1999 Sep; 277(3):G541-7. PubMed ID: 10484378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]